The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Abnormal accumulation of β‐amyloid (Aβ) peptide aggregates in the brain is a major hallmark of Alzheimer's disease (AD). Aβ aggregates interfere with neuronal communications, ultimately causing neuronal damage and brain atrophy. Much effort has been made to develop AD treatments that suppress Aβ aggregate formation, thereby attenuating Aβ‐induced neurotoxicity. Here, the design of Aβ nanodepletors...
In article number 1910475, Elena A. Rozhkova, Chan Beum Park, Joonseok Lee, and co‐workers design Aβ nanodepletors constructed from ultralarge mesoporous silica nanostructures and anti‐Aβ single chain variable fragments, which effectively capture monomeric Aβ peptides, inhibit Aβ aggregate formation, and attenuate Aβ‐mediated cytotoxicity. The Aβ‐targeting and clearing capabilities of the Aβ nanodepletors...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.